-
201
Efficacy of Esophageal Protector in Treating Gastroesophageal Reflux Disease with Extraesophageal Symptoms: a Multicenter, Open-Label, Observational Study
Published 2022-12-01“…The patients were recruited by 51 researchers in 26 cities of Russia. The study in chronological order consisted of a screening visit and two recorded visits (the observation period within the framework of the use of the Alfasoxx esophagoprotector). …”
Get full text
Article -
202
Pathogenetic Treatment of Gastritis as a Basis for the Prevention of Gastric Cancer in the Countries of the Commonwealth of Independent States: Literature Review and the Resolution...
Published 2018-09-01“…According to the standardized cancer mortality rate, gastric cancer takes the 1st place in Kyrgyzstan and Uzbekistan, 2nd — in Belarus, 3rd — in Kazakhstan, and 4th — in Armenia and Russia. In every case of H. pylori detection, it is important to make a decision about the expediency of eradication therapy. …”
Get full text
Article -
203
Real-world treatment patterns of patients with acute coronary syndrome based on 15-year data
Published 2024-12-01“…BACKGROUND: About half a million cases of acute coronary syndrome (ACS) are diagnosed in Russia every year. However, despite optimized treatment of patients with ACS, mortality remains high, which dictates the need to analyze the effectiveness of therapeutic measures. …”
Get full text
Article -
204
Blood and Iron: The Rise and Fall of the German Empire 1871 – 1918
Published 2024-12-01“…Following his terms as Ambassador in France and Russia, he was recalled to Berlin by Wilhelm I in 1862 to support passing the military budget. …”
Get full text
Article -
205
Резолюция Экспертного совета «Диагностика и лечение больных со сладжем в желчном пузыре»
Published 2018-08-01“…To present the data of Advisory council which took place on August 19, 2016 in Poland (Krakow) with the participation of Adamed Russia company. Summary. Advisory council activity provided the algorithm of diagnosis and treatment of biliary sludge. …”
Get full text
Article -
206
Features of development and progression of colorectal cancer on a background of ulcerative colitis
Published 2012-02-01“…Retrospective analysis of 65 cases with diagnosed CRC (2,1%) of 3154 patients with UC (treated in The State Scientific Centre of Coloproctology, Moscow, Russia from 1981 to 2010).Results. UC was diagnosed at the age of under 10 years in 5 patients (7,7%), from 10 to 19 years – in 16 (24,6%), 20–29 years – in 27 (41,5%), 30–39 years – in 4 (6,2%), 40–49 years – in 6 (9,2%), from 50 years and over – in 7 (10,8%). …”
Get full text
Article -
207
-
208
Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Co...
Published 2023-05-01“…The serological method cannot be used after anti-Helicobacter therapy.In Russia H. pylori strains' resistance to clarithromycin does not exceed 15 % in most regional studies. …”
Get full text
Article -
209
Treatment of Helicobacter pylori infection: mainstream and innovations (Review of the literature and Russian gastroenterological association Advisory council resolution, May 19, 20...
Published 2018-08-01“…The rate of clarithromycin resistance of H. pylori strains in Russia does not exceed 15% in the majority of regional studies. …”
Get full text
Article -
210
-
211
Assessment of Bowel Preparation Using Low-Volume Sulphate-Based Preparations in Comparison with Macrogols: A Multicenter, Randomized, Comparative Clinical Study of the 3rd Phase
Published 2019-03-01“…Oral sulphate solution (OSS: sodium sulphate, potassium sulphate and magnesium sulphate) is a low-volume osmotic agent for cleansing the intestines.Aim: in a multicentre, prospective, randomized, 3rd phase study with two parallel groups, the effectiveness, safety and tolerability of OSS was evaluated in comparison with Macrogol 4000 with electrolytes (a reference preparation for bowel cleansing in Russia) in adult patients who were scheduled for routine diagnostic colonoscopy.Methods. …”
Get full text
Article -
212
-
213
Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
Published 2014-07-01“…Efficacy and safety of this therapeutic mode were evaluated in intermediate analysis on 16-th week of treatment in 153 patients from Russia who have already reached the 16-th week of treatment or potentially can do so.Material and methods. …”
Get full text
Article -
214
Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association
Published 2018-08-01“…The prevalence of GERD in Russia ranges 1846%. Diagnosis of GERD early stages is based on the primary appealability and clinical presentation evaluation. …”
Get full text
Article -
215
Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
Published 2018-08-01“…According to the bulk of regional studies clarithromycin resistance level of H. pylori strains in Russia does not exceed 15%. Obtained data indicate the absence of high metronidazole-resistance of H. pylori as well as double resistance to clarithromycin and metronidazole. …”
Get full text
Article -
216
Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
Published 2018-08-01“…These qualities formed the basis for development of the Russian pegilated interferon-alpha 2b (Pegaltevir®, LLC «FARMAPARK», Russia) and carrying out doublestaged randomized open clinical trial: study of safety, tolerability and pharmacokinetics of Pegaltevir® at single injection of increasing doses in various groups of healthy volunteers - the I stage; studying of efficacy and safety of Pegaltevir® in comparison to PegIntron® (Schering-Plough, USA) at CHC as a part of double antiviral therapy with ribavirin (Rebetol®, Schering-Plough, USA) - the II stage. …”
Get full text
Article -
217